Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

VTAK
Catheter Precision, Inc.
stock NYSEAMERICAN

At Close
Jan 27, 2026 3:59:30 PM EST
2.12USD-5.357%(-0.12)13,831
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jan 22, 2026 9:09:30 AM EST
2.06USD-8.036%(-0.18)0
After-hours
Jan 27, 2026 4:29:30 PM EST
2.12USD0.000%(0.00)1,000
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrends
open chart   
open chart   
Market Cap
3.47M
Headquarters
Carlsbad, California, USA
Industry
Surgical and Medical Instrument Manufacturing
Last Split
Aug 15, 20251for19reverse
VTAK Stats
Avg. Vol. 10 Day
28,930
Avg. Vol. 30 Day
32,538
Market Cap
3,470,220
Shares Out.
1,668,375
On/Off Exchange
46%/54%
6 Month Beta
2.02
1 Year Beta
0.11
2 Year Beta
0.71
3 Year Beta
0.65
52 Week Low
1.49
52 Week High
15.68
SMA50
2.09
SMA200
3.45
1 Week
-0.48%
1 Month
+23.81%
3 Month
-20.91%
6 Month
-49.55%
1 Year
-73.27%
2 Year
-97.90%
Profile
advanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we believe our products enhance patients' quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. we currently manufacture and market two lines of products: dabra catheter and laser is cleared by the u.s. fda as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (pad), which commonly occurs in the legs. pharos excimer laser pharos is designed for use in the treatment of inflammatory skin conditions and is fda cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of

VTAK Stock Summary

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) stock price today is $2.12, and today's volume is 13,831. VTAK is down -5.357% today. The 30 day average volume is 32,538. VTAK market cap is 3.47M with 1,668,375 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC